Overall rank by patents
#48,777
of 49,997 tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 10 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01J (Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus).
The verdict
According to USPTO PatentsView, Mipsalus ranks #48,777 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 10 technology areas.
USPTO PatentsView assignee plate
Corpus R48777 · Foreign Corporation #48,777 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Mingsight Pharmaceuticals, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Mipsalus APS · this assignee
38 score
3D Lighting… · lowest
7 score
What this shows Mipsalus's Innovation Score is 38.4/100 (top 41% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Mipsalus APS is a focused PatentsView assignee: 10 CPC subclasses with 80% of grants classified under B01J (Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus). Peak complete grant year is 2015 (2 grants) versus a trough of 1 in 2021. By volume, Mipsalus sits between Mingsight Pharmaceuticals, Inc. and Miro Industries, Inc..
Mipsalus APS shows 2 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Mingsight Pharmaceuticals, Inc.
5 patents
Minima Technology Co., Ltd.
5 patents
Minmax Technology Co., Ltd.
5 patents
Mintron Energy Technology Co., Ltd.
5 patents
Miraevc Co., Ltd.
5 patents
Miraikikai, Inc.
5 patents
Mirna Therapeutics, Inc.
5 patents
Miro Industries, Inc.
5 patents
Mipsalus APS
5 patents
What this shows Mipsalus holds 5 patents at rank #48,648, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #48,648 in granted patent volume.
Other assignees with the most granted patents in Mipsalus's primary technology class.
Mipsalus's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
38 Top 41% higher than 59% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 40.0% |
| 2021 | 1 | 20.0% |
| 2023 | 1 | 20.0% |
| 2024 | 1 | 20.0% |
Top 10 of 10 technology areas
Overall rank by patents
#48,777
of 49,997 tracked assignees
38.4 out of 100
What to do with this data
Mipsalus APS's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.